We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp.
GERN 2.140-5.3%9:41 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Savant8/24/2018 12:26:12 PM
   of 3554
Geron up 42% on expectations of J&J continuing with imetelstat
Aug. 24, 2018 9:57 AM ET|About: Geron Corporation (GERN)|By: Douglas W. House, SA News Editor

Geron ( GERN +42.2%) is up on double normal volume in apparent response to a job posting for a pricing manager whose duties will include a setting a pricing approach for imetelstat, implying that its Janssen unit will continue development.

Janssen is expected to notify Geron on its decision this quarter.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext